These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 414606)
1. Pharmacology of the ductus arteriosus. Dipalma JR Am Fam Physician; 1978 Jan; 17(1):194-5. PubMed ID: 414606 [No Abstract] [Full Text] [Related]
2. The pharmacology of the ductus arteriosus. Smith GC Pharmacol Rev; 1998 Mar; 50(1):35-58. PubMed ID: 9549757 [No Abstract] [Full Text] [Related]
3. Comments on the pharmacologic manipulation of the ductus arteriosus in newborns. Rowe RD Adv Prostaglandin Thromboxane Res; 1978; 4():383-5. PubMed ID: 645513 [No Abstract] [Full Text] [Related]
4. Nonsurgical closure of patent ductus arteriosus in preterm infants. Smith ME Heart Lung; 1979; 8(2):308-10. PubMed ID: 253708 [No Abstract] [Full Text] [Related]
5. [Prospects for the use of prostaglandins in pediatric cardiology]. Zaorska B Kardiol Pol; 1981; 24(2):167-72. PubMed ID: 6788996 [No Abstract] [Full Text] [Related]
6. Blockers of prostaglandin synthesis: a novel therapy in the management of the premature human infant with patent ductus arteriosus. Friedman WF; Printz MP; Kirkpatrick SE Adv Prostaglandin Thromboxane Res; 1978; 4():373-81. PubMed ID: 565580 [No Abstract] [Full Text] [Related]
9. Patent ductus arteriosus. Clinical relevance of prostaglandins and prostaglandin inhibitors in PDA pathophysiology and treatment. Hammerman C Clin Perinatol; 1995 Jun; 22(2):457-79. PubMed ID: 7671547 [TBL] [Abstract][Full Text] [Related]
10. Medical treatment of the ductus arteriosus. Rudolph AM; Heymann MA Hosp Pract; 1977 Feb; 12(2):57-65. PubMed ID: 557025 [TBL] [Abstract][Full Text] [Related]
11. [Factors of motoricity of the ductus arteriosus]. Messer J; de Geeter B Pediatrie; 1978 Dec; 33(8):811-8. PubMed ID: 569274 [No Abstract] [Full Text] [Related]
12. Ductus arteriosus: developmental response to endogenous prostaglandins, oxygen, and indomethacin. Clyman RI Adv Prostaglandin Thromboxane Res; 1980; 7():887-90. PubMed ID: 6989208 [No Abstract] [Full Text] [Related]
13. Prostaglandins and the management of congenital heart disease. Taylor WJ; Alpert BS Am Fam Physician; 1982 Dec; 26(6):127-32. PubMed ID: 6890758 [TBL] [Abstract][Full Text] [Related]
14. Clinical use of prostaglandins and prostaglandin synthetase inhibitors in cardiac problems of the newborn. Olley PM; Coceani F; Rowe RD; Swyer PR Adv Prostaglandin Thromboxane Res; 1980; 7():913-6. PubMed ID: 6768235 [No Abstract] [Full Text] [Related]
15. The pharmacologic closure of the patent ductus arteriosus. Van Overmeire B; Chemtob S Semin Fetal Neonatal Med; 2005 Apr; 10(2):177-84. PubMed ID: 15701582 [TBL] [Abstract][Full Text] [Related]
16. Indomethacin and the patent ductus arteriosus. Nadas AS N Engl J Med; 1981 Jul; 305(2):97-8. PubMed ID: 7242581 [No Abstract] [Full Text] [Related]
17. [New aspects on the pathogenesis of patent ductus arteriosus in premature infants]. Seyberth HW Monatsschr Kinderheilkd; 1986 Jul; 134(7):423-35. PubMed ID: 3528823 [TBL] [Abstract][Full Text] [Related]
18. [Long-term treatment using prostaglandin E2 in congenital heart defects with the pulmonary circulation being supplied by a patent ductus arteriosus]. Hruda J; Samánek M; First T; Vorísková M; Skovránek J Cesk Pediatr; 1985 May; 40(5):257-62. PubMed ID: 3860302 [No Abstract] [Full Text] [Related]
19. The fetal ductus arteriosus, a review. Brezinka C; Gittenberger-de Groot AC; Wladimiroff JW Zentralbl Gynakol; 1993; 115(10):423-32. PubMed ID: 8273432 [TBL] [Abstract][Full Text] [Related]